Notice of Conversion by DMBM Inc. for VG Life Sciences Inc. Unsecured Convertible Debentures
DMBM Inc. has notified VG Life Sciences Inc. of its decision to convert $68,000 of principal from previously acquired unsecured convertible debentures into 1,360,000 shares of VG Life Sciences' common stock. This conversion is made under the terms of prior Note Purchase Agreements and a Release and Settlement Agreement. The conversion is effective as of September 11, 2014, and is executed by an authorized officer of DMBM Inc.
Exhibit 10.143
September 11, 2014
VG Life Sciences Inc.
2290 Huntington Drive, Suite 100
San Marino, CA 91108
Tel: 626 ###-###-####
Dear Mr Keledjian,
NOTICE OF CONVERSION
The undersigned hereby elects to convert principal under the Unsecured Convertible Debentures of VG Life Sciences, Inc., a Delaware corporation (the “Company”), that has been duly paid for and acquired by DMBM Inc. under the Note Purchase Agreements dated August 1, 2013, December 1, 2013 and January 31, 2014 and converted under the Release and Settlement Agreement dated July 1, 2013, into shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company according to the conditions hereof, as of the date written below.
| Conversion calculations: | $68,000 / $0.05 = 1,360,000 shares |
| Date to Effect Conversion: | September 11, 2014 |
| Principal Amount of Debenture to be converted: | $68,000 |
| Number of shares of Common Stock to be issued: | 1,360,000 |
| DMBM, Inc. | |
| /s/ Damon R Devitt | |
| Damon R Devitt | |
| Duly authorized officer |
